Kymera Therapeutics KYMR
NASDAQ KYMR
$117.45 +0.17 (+0.14%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2026)

Kymera Therapeutics (KYMR) posted quarterly Prepaid Assets of $26.5 million for Q1 2026, up 48.88% year-over-year from $17.8 million in Q1 2025, and up 15.54% quarter-over-quarter from $22.9 million in Q4 2025.

Analysis

Kymera Therapeutics (KYMR) Prepaid Assets (2019 - 2026) Analysis & Trends

Kymera Therapeutics (KYMR) has reported Prepaid Assets for 8 consecutive years, with $26.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 48.88% year-over-year to $26.5 million; the TTM figure through Mar 2026 stood at $26.5 million (up 48.88% YoY), while the FY2025 annual figure was $22.9 million, up 6.57% from the prior year.
  • Prepaid Assets improved to $26.5 million in Q1 2026 per KYMR's latest filing, from $22.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $26.5 million in Q1 2026 and bottomed at $8.1 million in Q2 2022.
  • Historically, Prepaid Assets has averaged $15.7 million across 5 years, with a median of $14.1 million in 2023.
  • On a YoY basis, Prepaid Assets climbed as much as 84.38% in 2024 and fell as far as 0.32% in 2024.
  • Kymera Therapeutics' Prepaid Assets stood at $9.7 million in 2022, then increased by 20.19% to $11.7 million in 2023, then surged by 84.38% to $21.5 million in 2024, then advanced by 6.57% to $22.9 million in 2025, then advanced by 15.54% to $26.5 million in 2026.
  • Business Quant data shows KYMR's Prepaid Assets at $26.5 million in Q1 2026, $22.9 million in Q4 2025, and $22.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kymera Therapeutics 11.52 Bn 10.83 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.28 Mn
Mar 31, 2026 26.50 Mn
Dec 31, 2025 22.94 Mn
Sep 30, 2025 22.62 Mn
Jun 30, 2025 22.88 Mn
Mar 31, 2025 17.80 Mn
Dec 31, 2024 21.52 Mn
Sep 30, 2024 17.43 Mn
Jun 30, 2024 13.75 Mn
Mar 31, 2024 14.68 Mn
Dec 31, 2023 11.67 Mn
Sep 30, 2023 14.09 Mn
Jun 30, 2023 13.71 Mn
Mar 31, 2023 11.35 Mn
Dec 31, 2022 9.71 Mn
Sep 30, 2022 9.23 Mn
Jun 30, 2022 8.09 Mn
Mar 31, 2022 9.31 Mn
Dec 31, 2021 8.72 Mn
Sep 30, 2021 5.77 Mn